1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
2 |
Bade BC, Cruz CSD. Lung cancer 2020: epidemiology, etiology, and prevention[J]. Clin Chest Med, 2020, 41(1): 1-24.
|
3 |
Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States[J]. Cancer Lett, 2020, 468: 82-87.
|
4 |
Chiang XH, Lu TP, Hsieh MS, et al. Thoracoscopic wedge resection versus segmentectomy for cT1N0 lung adenocarcinoma[J]. Ann Surg Oncol, 2021: 1-14.
|
5 |
Ishida H, Yanagihara A, Taguchi R, et al. NEWS technique: easy and reliable thoracoscopic wedge resections of lung tumors[J]. J Thoracic Disease, 2020, 12(8): 4571.
|
6 |
耿 倩,申 乐. 围术期持续静脉输注利多卡因在多模式镇痛中的应用和机制探讨[J]. 临床药物治疗杂志,2018, 16(2): 80-83.
|
7 |
郑晓静,疏树华. 多模式镇痛在术后快速康复中的临床研究进展[J]. 医学综述,2019, 25(4): 800-804.
|
8 |
倪 跃,龚 立,宁仁德,等. PKP结合明胶海绵辅助利多卡因治疗胸腰椎骨折的疗效分析[J]. 颈腰痛杂志,2019, 40(2): 170-172.
|
9 |
Lee SM, Park CM, Paeng JC, et al. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule[J]. Eur Radiol, 2012, 22(7): 1556-1563.
|
10 |
孙志超,吴仪仪,余仲飞,等. 增强CT与PET/CT在诊断肺癌及其淋巴结转移中的价值[J]. 医学研究杂志,2014, 43(10): 42-45.
|
11 |
廖 晨,余祖滨,张 萍,等. 慢性阻塞性肺疾病合并肺癌122例临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(1): 25-29.
|
12 |
李兰曼,魏 玮. 肺癌流行病学和危险因素研究进展[J]. 肿瘤研究与临床,2018, 30(12): 875-879.
|
13 |
王伟明,柴 琴,王桂华. 2004年和2014年长沙城区肺结核合并肺癌流行病学比较分析[J]. 现代肿瘤医学,2016, 24(9): 1463-1466.
|
14 |
毕惠娟,方文浩,薛 莹,等. 肺癌四项血清学指标在肺癌患者中的表达与临床应用价值[J]. 安徽医学,2020, 41(5): 540-543.
|
15 |
王霄鹏,吴思思,武海龙. 达克罗宁联合利多卡因表面麻醉用于抑制心血管反射的临床效果[J]. 实用临床医药杂志,2019, 23(4): 99-101.
|
16 |
谢奇朋,崔常雷,贺 超,等. 比较罗哌卡因和利多卡因表面麻醉在颅内动脉瘤夹闭术中对气管插管及拔管时应激反应的影响[J]. 中国实验诊断学,2019, 23(2): 284-286.
|
17 |
徐明霞,方 波. 静脉注射利多卡因在消化道肿瘤患者全身麻醉中的应用[J]. 中国医师杂志,2018, 20(11): 1749-1751.
|
18 |
孙艳霞,宋晓丽,柴 芳,等. 静脉输注利多卡因对腹腔镜胆囊切除手术术后恢复的影响:随机三盲对照临床研究[J]. 国际麻醉学与复苏杂志,2018, 39(3): 204-207.
|
19 |
刘芳妍,范 隆,王天龙. 静脉输注利多卡因对术后胃肠功能的影响[J]. 北京医学,2017, 39(6): 628-630.
|
20 |
刘子嘉,张良燕,郑旭光,等. 术中利多卡因持续静脉泵入对胸腔镜肺叶切除术患者阿片类用量及术后恢复的影响[J]. 中国医学科学院学报,2018, 40(2): 163-169.
|
21 |
Ibrahim TH. Lidocaine and dexmedetomidine combined infusion as an alternative to propofol for sedation in colonoscopy[J]. Ain-Shams J Anesthesiol, 2021, 13(1): 1-7.
|
22 |
Fedorova IM, Tikhonov DB. Lidocaine and carbamazepine inhibit while phenytoin and lamotrigine paradoxically enhance the insect neuromuscular transmission[J]. Invertebr Neurosci, 2019, 19(1): 1-8.
|
23 |
Huang W, Ke Y, Zhu J, et al. TRESK channel contributes to depolarization-induced shunting inhibition and modulates epileptic seizures[J]. Cell Reports, 2021, 36(3): 109404.
|
24 |
Wang F, Ma SB, Tian ZC, et al. Nociceptor-localized cGMP-dependent protein kinase I is a critical generator for central sensitization and neuropathic pain[J]. Pain, 2021, 162(1): 135-151.
|
25 |
王 巧,王 军,解成兰. 围术期静脉应用利多卡因的研究进展[J]. 新医学,2020, 51(1): 12-16.
|
26 |
赵楠溪,曹学照,王 俊. 利多卡因持续静脉输注对腹腔镜结直肠手术患者术后疼痛的影响[J]. 中国医科大学学报,2019, 48(2): 136-139.
|
27 |
陈 菲,王忠慧,陈 亮. 静注利多卡因对行乳腺癌根治术患者术后镇痛的干预效果[J]. 昆明医科大学学报,2020, 41(1): 84-86.
|
28 |
Puri L, Morgan KJ, Anghelescu DL. Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease[J]. Current Opin Support Palliat Care, 2019, 13(4): 402-407.
|
29 |
Abdelrahman I, Steinvall I, Elmasry M, et al. Lidocaine infusion has a 25% opioid-sparing effect on background pain after burns: a prospective, randomised, double-blind, controlled trial[J]. Burns, 2020, 46(2): 465-471.
|
30 |
Sahmeddini MA, Khosravi MB, Farbood A. Comparison of perioperative systemic lidocaine or systemic ketamine in acute pain management of patients with opioid use disorder after orthopedic surgery[J]. J Addict Med, 2019, 13(3): 220-226.
|